Literature DB >> 8613952

Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. IV. Regulation by external Ca++ of alpha-bungarotoxin-sensitive receptor function and of rectification induced by internal Mg++.

R Bonfante-Cabarcas1, K L Swanson, M Alkondon, E X Albuquerque.   

Abstract

Applying the whole-cell mode of the patch-clamp technique to cultured hippocampal neurons, we demonstrated that extracellular Ca++ modulates the activation and inactivation of type IA nicotinic currents, ie., the currents subserved by alpha-bungarotoxin (alpha-BGT)-sensitive, alpha-7-containing nicotinic acetylcholine receptors (nAChRs). The rundown profile of acetylcholine (ACh)-induced type IA currents that were obtained using patch pipettes filled with F(-)-based internal solution had two components: the first component of rundown was counteracted by a more physiological internal solution containing an organic anion (malate or aspartate), suggesting energy dependence; the second component exhibited dependence on concentration of CaCl2 added to the external solution ([Ca++]o), with rundown minimized at 0.32 mM. The inward rectification of Ach-elicited type IA currents, induced by intracellular Mg++ was augmented by lowering [Ca++]o (from 2 to 0.32 mM). Moreover, extracellular Ca++ (0.01-10 mM) acted in a concentration-dependent manner (IC50 = 0.26 mM) to decrease the cooperativity induced by ACh (nH was reduced from 2.7 to 1). Extracellular Ca++ (EC50 = 0.1 mM) also increased the efficacy of ACh, but exposure to [Ca++]o from 1 to 32 mM decreased the efficacy of ACh and inactivated the alpha-BGT-sensitive nAChRs (IC50 = 11 mM). In conclusion, Ca++ regulates agonist efficacy and cooperativity at the alpha-BGT-sensitive neuronal nAChR, modulates rundown and counteracts Mg++ -dependent inward rectification of type IA currents. It is suggested that the regulation by Ca++ of the alpha-BGT-sensitive nAChR activity could modulate many neuronal functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613952

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission.

Authors:  K A Radcliffe; J A Dani
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

2.  Actin filaments and the opposing actions of CaM kinase II and calcineurin in regulating alpha7-containing nicotinic receptors on chick ciliary ganglion neurons.

Authors:  Q s Liu; D K Berg
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

3.  Biophysical and pharmacological characterization of nicotinic cholinergic receptors in rat cochlear inner hair cells.

Authors:  María Eugenia Gómez-Casati; Paul A Fuchs; Ana Belén Elgoyhen; Eleonora Katz
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

4.  Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.

Authors:  B Buisson; M Gopalakrishnan; S P Arneric; J P Sullivan; D Bertrand
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 5.  Naturally-expressed nicotinic acetylcholine receptor subtypes.

Authors:  Jie Wu; Ronald J Lukas
Journal:  Biochem Pharmacol       Date:  2011-07-20       Impact factor: 5.858

6.  Functional distribution of nicotinic receptors in CA3 region of the hippocampus.

Authors:  Michael Grybko; Geeta Sharma; Sukumar Vijayaraghavan
Journal:  J Mol Neurosci       Date:  2009-08-20       Impact factor: 3.444

7.  Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.

Authors:  Roger L Papke; Julia K Porter Papke
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

8.  Selectively driving cholinergic fibers optically in the thalamic reticular nucleus promotes sleep.

Authors:  Kun-Ming Ni; Xiao-Jun Hou; Ci-Hang Yang; Ping Dong; Yue Li; Ying Zhang; Ping Jiang; Darwin K Berg; Shumin Duan; Xiao-Ming Li
Journal:  Elife       Date:  2016-02-11       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.